Spero Therapeutics company info

What does Spero Therapeutics do?
Spero Therapeutics (NASDAQ:SPRO) focuses on developing treatments for multi-drug resistant bacterial infections. With a robust pipeline primarily targeting the most critical and hard-to-treat bacterial infections, Spero is committed to innovating within the field of antibiotic development. The company's projects span across various stages of clinical development, aiming to address the growing global threat of antimicrobial resistance. One of their key objectives includes advancing their lead candidates through clinical trials to bring novel therapies to patients in need, while also exploring potential in antibacterial and diagnostic products to broaden their impact on public health. Spero Therapeutics is driven by a mission to save lives by revitalizing the arsenal against bacterial infections.
Spero Therapeutics company media
Company Snapshot

Is Spero Therapeutics a public or private company?

key
Ownership
Public

How many people does Spero Therapeutics employ?

people
Employees
46

What sector is Spero Therapeutics in?

pie chart
Sector
Health Care

Where is the head office for Spero Therapeutics?

location pin
Head Office
Massachusetts, United States

What year was Spero Therapeutics founded?

founded flag
Year Founded
2013
What does Spero Therapeutics specialise in?
/Antibacterial Therapeutics /Drug Development /Clinical Trials /Multi-Drug Resistant /Innovative Treatments /Biopharmaceutical Company

What are the products and/or services of Spero Therapeutics?

Overview of Spero Therapeutics offerings
"SPR206, an IV-administered agent aimed at combating multidrug-resistant Gram-negative bacteria"
"SPR720, an oral therapy for non-tuberculous mycobacterial (NTM) infections"
"Potentiator platform, enhancing the performance of existing antibiotics against resistant bacteria"
"SPR994, an oral formulation of tebipenem, targeting complicated urinary tract infections (cUTI)"
"Collaborations with government and industry partners to develop and commercialize novel antimicrobial agents"

Who is in the executive team of Spero Therapeutics?

Spero Therapeutics leadership team
  • Dr. Ankit  Mahadevia M.D., MBA
    Dr. Ankit Mahadevia M.D., MBA
    Co-Founder & Chairman of the Board
  • Mr. Satyavrat  Shukla C.F.A.
    Mr. Satyavrat Shukla C.F.A.
    President, CEO & Director
  • Mr. Timothy  Keutzer
    Mr. Timothy Keutzer
    Chief Operating Officer
  • Ms. Esther P. Rajavelu
    Ms. Esther P. Rajavelu
    CFO & Chief Business Officer
  • Ted  Jenkins
    Ted Jenkins
    VP & Head of Investor Relations
  • Mr. James P. Brady
    Mr. James P. Brady
    Chief Human Resource Officer
  • Dr. Kamal  Hamed M.B.A., M.D., M.P.H.
    Dr. Kamal Hamed M.B.A., M.D., M.P.H.
    Chief Medical Officer